Bio-Rad Laboratories Inc (BIO)

Financial leverage ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total assets	US$ in thousands	12,299,100	11,895,900	11,978,200	13,667,400	13,501,700	12,058,500	12,682,100	14,373,700	17,799,400	19,953,400	15,117,600	13,933,200	12,972,600	12,020,900	10,097,300	8,684,360	8,008,860	7,177,100	7,646,900	6,862,900
Total stockholders’ equity	US$ in thousands	8,741,130	8,416,200	8,446,890	9,763,720	9,615,250	8,477,470	8,945,040	10,203,300	13,685,200	15,332,400	11,594,900	10,609,100	9,889,690	8,825,140	7,353,400	6,293,080	5,756,840	5,131,190	5,486,810	4,863,860
Financial leverage ratio		1.41	1.41	1.42	1.40	1.40	1.42	1.42	1.41	1.30	1.30	1.30	1.31	1.31	1.36	1.37	1.38	1.39	1.40	1.39	1.41

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $12,299,100K ÷ $8,741,130K
= 1.41

The financial leverage ratio of Bio-Rad Laboratories Inc. has been relatively stable over the past eight quarters, ranging from 1.40 to 1.43. This indicates that the company relies more on debt financing than equity financing in its capital structure. A financial leverage ratio above 1 suggests that the company has more debt than equity in its capital structure, which can magnify returns on equity but also increases financial risk. Despite minor fluctuations in the ratio, it appears that Bio-Rad Laboratories Inc. has maintained a consistent level of leverage over the observation period. Further analysis could be conducted to assess the impact of the company's leverage on its financial performance and risk profile.